Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Both funds offer diversification; index funds are passive and typically cheaper. This comparison highlights key differences to inform your choice.
24,304 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Oil prices extend gains, pushing Dow futures lower as traders brace for inflation data and central-bank signals. Vola...
Silver sank sharply as the Federal Reserve signaled no quick rate cuts, fueling a silver price prediction: lost debat...
Cybersecurity stocks tumbled as Anthropic rolled out a new AI model, sending Palo Alto Networks and other peers lower...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
Markets cooled early May 2026 as inflation data rolled in, but investors pressed ahead with digital planning. This re...
New data shows that delaying retirement savings by ten years can wipe out roughly $1.1 million in compounded gains, a...
A Hollywood anecdote offers surprisingly practical money lessons. This article translates the idea behind paul rudd s...
Samsung Electronics is under a developing insider-trading investigation as regulators scrutinize stock moves tied to ...
Motor oil prices are rising as geopolitical tensions around Iran disrupt supply chains. Even with a tentative deal on...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
As inflation erodes purchasing power, a decades-old rule could push a larger portion of retirement income into taxabl...